首页> 外文期刊>BioMed research international >The Role of Targeted Temperature Management in Adult Patients Resuscitated from Nonshockable Cardiac Arrests: An Updated Systematic Review and Meta-Analysis
【24h】

The Role of Targeted Temperature Management in Adult Patients Resuscitated from Nonshockable Cardiac Arrests: An Updated Systematic Review and Meta-Analysis

机译:靶向温度管理在成人患者中的作用从非应用的心脏骤停复苏:更新的系统审查和荟萃分析

获取原文
获取原文并翻译 | 示例
           

摘要

Routine targeted temperature management is recommended for comatose adult patients with return of spontaneous circulation after cardiac arrest. However, the role of targeted temperature management in patients resuscitated from nonshockable cardiac arrests remains uncertain. We conducted an updated systematic review and meta-analysis to evaluate the effects of targeted temperature management in this population. Medline, EMBASE, and Cochrane databases were systematically reviewed for studies published between January 2005 and March 2016, in which targeted temperature management was compared with standard care or normothermia for adult patients resuscitated from nonshockable cardiac arrests. A total of 25 trials that included 5715 patients were identified from 10985 relevant papers. Pooled data showed that targeted temperature management not only associated with improved short-term survival (RR = 1.42, 95% CI: 1.28-1.57) and neurological function (RR = 1.63, 95% CI: 1.39-1.91) but also associated with improved long-term survival (RR = 1.64,95% CI: 1.27-2.12) and neurological recovery (RR = 1.42,95% CI: 1.07-1.90) in observational cohort studies. However, more frequent infectious complications were reported in hypothermia-treated patients (RR = 1.46,95% CI: 1.26-1.70) and the quality of the evidence ranged from moderate to very low.
机译:常规目标温度管理推荐用于COMATOSE成人患者,随后心脏骤停后自发循环恢复。然而,靶向温度管理在从非可卡心脏骤停的患者中的作用仍然不确定。我们进行了更新的系统审查和META分析,以评估该群体中有针对性的温度管理的影响。系统地审查了2005年1月至2016年3月在2016年1月至2016年3月期间发布的研究的研究,其中将有针对性的温度管理与从非可卡心脏骤停的成人患者进行标准护理或常温。共有25项试验中包含5715名患者的相关文件。汇总数据显示,目标温度管理不仅与改善的短期存活(RR = 1.42,95%CI:1.28-1.57)和神经功能(RR = 1.63,95%CI:1.39-1.91)相关,还与改善相关长期存活(RR = 1.64,95%CI:1.27-2.12)和神经恢复(RR = 1.42,95%CI:1.07-1.90)在观察队列研究中。然而,在低温治疗的患者中报告了更频繁的传染性并发​​症(RR = 1.46,95%CI:1.26-1.70)和证据的质量范围从中等到很低。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号